4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001079
Chief Scientific Officer sold 1,412 shares at $16.65 ($23,510)
- Chief Scientific Officer acquired 1,412 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ordentlich Peter Chief Scientific Officer | 2022-01-31 | Other acquisition | +1,412 | $12.39 | $17,495 | 1,412 | D: show line 1 in the form |
| Ordentlich Peter Chief Scientific Officer | 2022-02-01 | Sale | −1,412 | $16.65 | $23,510 | 0 | D: show line 2 in the form |
| Open-market sales · 1,412 sh · avg $16.65 · $23,510 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ordentlich Peter Chief Scientific Officer | 2022-02-02 | Grant or award · Stock Options (Right to buy) | +80,000 | $15.79 | $1,263,200 | 80,000 | D: show line 3 in the form |
Loading xslF345X03/primarydocument.xml…